Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates

Codexis (CDXS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of$ 0.25. This compares to loss of $0.26 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -16%. A quarter ago, it was expected that this producer of custom industrial enzymes would post a loss of$ 0.26 per share when it actually produced a loss of $0.32, delivering a surprise of -23.08%.Over the last four quarters, the ...